All In Biotech

Drug Trial Radar · NCT07712562

A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes

A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Dibotatug in Adults With Bone Marrow Failure Syndromes

Last checked: Nov 19, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Aug 14, 2026

Primary completion

Apr 2029

Study completion Oct 2030

Sponsor

Lead sponsor
Dren BioIndustry
Sponsor type
Industry
First posted
Jul 17, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, open-label, Phase 1/2 basket study to evaluate the safety and efficacy of Dibotatug (DR-01) in adults with Bone Marrow Failure syndromes.

Conditions

  • Bone Marrow Failure Syndromes
  • Aplastic Anemias
  • Severe Aplastic Anemia (SAA)
  • Severe Aplastic Anemia, Relapse
  • Severe Aplastic Anemia, Refractory
  • Non-severe Aplastic Anemia

Interventions

  • Dibotatug (DR-01)Drug

    Dibotatug (DR-01) administered by IV infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Response Rate of Dibotatug (defined as proportion of subjects with a Complete Response or Partial Response) [Efficacy]Time frame: By 6 months
  2. Incidence and severity of adverse events as assessed by CTCAE v6.0 [Safety and Tolerability]Time frame: 52 weeks

Locations

10 sites in 1 country. Site status is shown where the registry gives one.

  • Dren Investigational Site

    Duarte, California · Not yet recruiting

  • Dren Investigational Site

    Palo Alto, California · Not yet recruiting

  • Dren Investigational Site

    Miami, Florida · Not yet recruiting

  • Dren Investigational Site

    Atlanta, Georgia · Recruiting

  • Dren Investigational Site

    New York, New York · Recruiting

  • Dren Investigational Site

    Cleveland, Ohio · Not yet recruiting

  • Dren Investigational Site

    Columbus, Ohio · Not yet recruiting

  • Dren Investigational Site

    Houston, Texas · Not yet recruiting

  • Dren Investigational Site

    Fairfax, Virginia · Not yet recruiting

  • Dren Investigational Site

    Seattle, Washington · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.